Once-a-month drug for osteoporosis soon to launch.

Published: 2007-04-23 06:58:00

Updated: 2007-04-23 06:58:00

A tensional atmosphere seems to surface to the 130 billion won worth of anti-osteoporosis drug markets by upcoming market launch of a new once-a-month administering drug, perhaps within this week at the earlist.

Currently the bisphosphonate anti-osteoporosis drugs occupied 80% of the 100 bill...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK